<?xml version="1.0" encoding="UTF-8"?>
<p>An attempt has been done by Fjelbye et al. to elucidate the effect of replacing a hydrogen atom with fluorine on the pKa and P-glycoprotein (Pgp)-mediated efflux for a series of phosphodiesterase type 9 (PDE9) inhibitors [
 <xref rid="B6-molecules-25-04677" ref-type="bibr">6</xref>]. A harmonic trend has been noted in the pKa shift for the synthesized compounds 
 <bold>1</bold> (
 <xref ref-type="fig" rid="molecules-25-04677-f001">Figure 1</xref>) after hydrogenâ€“fluorine replacement. Consequently, these possibilities or limitations which are afforded by fluorine can be beneficial in drug discovery.
</p>
